Concepedia

Steven L. Kuklish

SL

Statistics

Publications

11

Citations

301

H-Index

10

Active since

2006

Affiliations

Eli Lilly (United States)(Current)

Steven L. Kuklish is an author at Eli Lilly (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2006–2018

11

Publications

11

Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics

J.G. Luz, Stephen Antonysamy, Steven L. Kuklish et al. · Journal of Medicinal Chemistry · 2015 · 65 citations · Full text

, , +14

Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors

Matthew A. Schiffler, Stephen Antonysamy, Shobha Bhattachar et al. · Journal of Medicinal Chemistry · 2015 · 54 citations · Full text

, , +16

3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity

Matthew J. Fisher, Ryan T. Backer, Vanessa Barth et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 29 citations · Full text

, , +5

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Katherine M. Partridge, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

, , +6

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Steven L. Kuklish, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 26 citations · Full text

, , +11

1–5 of 11